Thermo Fisher presents diagnostic solutions at ADLM 2026
The press release highlights FDA clearances for EXENT multiple myeloma test and EliA CTD 13 screen, plus LabLink360 software.
See the latest news and media coverage for Thermo Fisher. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life sciences technology and services company
thermofisher.comLast updated
In short: Thermo Fisher Scientific sold its microbiology business for $1 billion, reported strong Q2 2026 growth, and acquired Clario for $8.9 billion.
The press release highlights FDA clearances for EXENT multiple myeloma test and EliA CTD 13 screen, plus LabLink360 software.
The media-on-demand workflow simplifies media preparation and supports traceable enrichment testing.
Revenue reached $11.99B with adjusted EPS of $6.03, reflecting strong end market demand and new product launches.
The approval enables Rapid DNA profiles to be searched in the national CODIS database, accelerating investigations.
Astorg, a private equity firm, has acquired the global microbiology business of Thermo Fisher Scientific.
European private equity firm Astorg will run the business as an independent diagnostics company, led...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or...
Researchers were able to modify DNA samples from crime-scene forensics using an AI tool.
Track Thermo Fisher and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Thermo Fisher and other trending companies.